Advertisement

Long-term Use and Safety of JAK Inhibitors and Evaluating Efficacy Outcomes in Atopic Dermatitis - Episode 5

AD: Efficacy Outcomes

Published on: 

Christopher G. Bunick, MD, PhD, discusses underutilized efficacy outcomes in atopic dermatitis (AD) clinical trials.

Advertisement
Advertisement